Genmab A/S (GNMSF)
301.28
-0.69
(-0.23%)
USD |
OTCM |
May 17, 16:00
Genmab 1 Year Total Returns (Daily): -26.06% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -26.06% |
| May 16, 2024 | -26.72% |
| May 15, 2024 | -31.26% |
| May 14, 2024 | -31.53% |
| May 13, 2024 | -33.11% |
| May 10, 2024 | -27.38% |
| May 09, 2024 | -28.69% |
| May 08, 2024 | -31.23% |
| May 07, 2024 | -30.29% |
| May 06, 2024 | -27.18% |
| May 03, 2024 | -28.90% |
| May 02, 2024 | -31.64% |
| May 01, 2024 | -33.25% |
| April 30, 2024 | -32.90% |
| April 29, 2024 | -33.44% |
| April 26, 2024 | -32.61% |
| April 25, 2024 | -34.07% |
| April 24, 2024 | -32.09% |
| April 23, 2024 | -29.67% |
| April 22, 2024 | -29.83% |
| April 19, 2024 | -29.13% |
| April 18, 2024 | -29.72% |
| April 17, 2024 | -34.03% |
| April 16, 2024 | -30.88% |
| April 15, 2024 | -31.64% |
| Date | Value |
|---|---|
| April 12, 2024 | -26.13% |
| April 11, 2024 | -22.96% |
| April 10, 2024 | -22.46% |
| April 09, 2024 | -22.72% |
| April 08, 2024 | -23.78% |
| April 05, 2024 | -22.75% |
| April 04, 2024 | -20.49% |
| April 03, 2024 | -22.66% |
| April 02, 2024 | -19.87% |
| April 01, 2024 | -20.88% |
| March 28, 2024 | -16.87% |
| March 27, 2024 | -19.93% |
| March 26, 2024 | -17.23% |
| March 25, 2024 | -18.68% |
| March 22, 2024 | -17.72% |
| March 21, 2024 | -19.18% |
| March 20, 2024 | -19.97% |
| March 19, 2024 | -18.60% |
| March 18, 2024 | -17.96% |
| March 15, 2024 | -15.10% |
| March 14, 2024 | -14.12% |
| March 13, 2024 | -12.57% |
| March 12, 2024 | -10.71% |
| March 11, 2024 | -10.39% |
| March 08, 2024 | -14.12% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-40.37%
Minimum
Jun 14 2022
115.2%
Maximum
Mar 16 2021
20.76%
Average
15.99%
Median
Jan 09 2023
1 Year Total Returns (Daily) Benchmarks
| Ascendis Pharma A/S | 33.69% |
| Galecto Inc | -73.05% |
| Evaxion Biotech AS | -77.45% |
| IO Biotech Inc | -32.02% |